OXANDROLONE FOR THE TREATMENT OF MARROW APLASIA IN FANC*
$0R01FY2005FDFDA
Children'S Hospital Med Ctr (Cincinnati), Cincinnati OH
Investigators
Linked publications, trials & patents
Abstract
Abstract Not Provided
View original record on NIH RePORTER →